Transformation‐Associated Epstein‐Barr Virus Antigens as Targets for Immune Attacka
- 1 August 1993
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 690 (1) , 86-100
- https://doi.org/10.1111/j.1749-6632.1993.tb43999.x
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.The Journal of Experimental Medicine, 1992
- Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.The Journal of Experimental Medicine, 1992
- The epstein-barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cellsInternational Journal of Cancer, 1991
- An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).The Journal of Experimental Medicine, 1990
- Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative DiseaseNew England Journal of Medicine, 1989
- Detection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's DiseaseNew England Journal of Medicine, 1989
- Absence, or low expression, of leukocyte adhesion molecules CDI1 and CD18 on burkjtt lymphoma cellsInternational Journal of Cancer, 1988
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985
- HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell coloniesInternational Journal of Cancer, 1984